Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (281-290 of 853) with videos related to

Pageof 86
Sort By:
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
A phase II study of sequential methotrexate and 5-fluorouracil in colorectal carcinomaM J Harding, S B Kaye, M Soukop, et al.
American Journal of Health Education|March 13, 2018
Motivators of and Barriers to Engaging in Physical Activity: Perspectives of Low-Income Culturally Diverse Adolescents and AdultsMarie A Bragg, Carolyn M Tucker, Lily B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overviewS B Kaye, M Piccart, M Aapro, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Cutaneous vasculitis associated with interferonG Sangster, S B Kaye, K C Calman, et al.
Clinical & Experimental Ophthalmology|June 13, 2006
50-year-old transplants in the centenary year of corneal transplantationDan Q Nguyen, Steven Nicholson, Say A Quah, et al.
Journal of Medicinal Chemistry|January 1, 1970
The inhibition of viral neuraminidase by 1-phenoxymethyl-3,4-dihydroisoquinolines. I. Steric effectsM S Tute, K W Brammer, B Kaye, et al.
British Journal of Urology|May 1, 1990
Low dose methotrexate and doxorubicin in hormone-resistant prostatic cancer. Scottish Urological Oncology GroupM F Smith, A H Lawson, D Kirk, et al.
British Journal of Cancer|June 1, 1988
Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16M A Smith, S Merry, J G Smith, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1988
Onco-developmental protein concentrations in the sera of patients with ovarian cancer prior to treatmentD R Pledger, A Belfield, J H Kennedy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Distribution of doxorubicin to normal breast and tumour tissue in patients undergoing mastectomyS Stallard, J G Morrison, W D George, et al.
Pageof 86

Showing results (281-290 of 853) with videos related to

Sort By:
Pageof 86
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
A phase II study of sequential methotrexate and 5-fluorouracil in colorectal carcinomaM J Harding, S B Kaye, M Soukop, et al.
American Journal of Health Education|March 13, 2018
Motivators of and Barriers to Engaging in Physical Activity: Perspectives of Low-Income Culturally Diverse Adolescents and AdultsMarie A Bragg, Carolyn M Tucker, Lily B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overviewS B Kaye, M Piccart, M Aapro, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Cutaneous vasculitis associated with interferonG Sangster, S B Kaye, K C Calman, et al.
Clinical & Experimental Ophthalmology|June 13, 2006
50-year-old transplants in the centenary year of corneal transplantationDan Q Nguyen, Steven Nicholson, Say A Quah, et al.
Journal of Medicinal Chemistry|January 1, 1970
The inhibition of viral neuraminidase by 1-phenoxymethyl-3,4-dihydroisoquinolines. I. Steric effectsM S Tute, K W Brammer, B Kaye, et al.
British Journal of Urology|May 1, 1990
Low dose methotrexate and doxorubicin in hormone-resistant prostatic cancer. Scottish Urological Oncology GroupM F Smith, A H Lawson, D Kirk, et al.
British Journal of Cancer|June 1, 1988
Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16M A Smith, S Merry, J G Smith, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1988
Onco-developmental protein concentrations in the sera of patients with ovarian cancer prior to treatmentD R Pledger, A Belfield, J H Kennedy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Distribution of doxorubicin to normal breast and tumour tissue in patients undergoing mastectomyS Stallard, J G Morrison, W D George, et al.
Pageof 86